Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Friday, April 4, 2025
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Europe’s pharma industry braces for tariffs as carve-out hopes fade

April 2, 2025
in News
Reading Time: 3 mins read
A A
Europe’s pharma industry braces for tariffs as carve-out hopes fade
0
SHARES
ShareShareShareShareShare

READ ALSO

Mohamed El-Erian says Trump tariffs risk US recession

China’s response to U.S. tariffs will likely focus on stimulus, trade

SEIZED OZEMPIC, WEGOVY AND OTHER WEIGHT LOSS DRUGS AT JFK AIRPORT’S INTERNATIONAL MAIL FACILITY.

CNBC

COPENHAGEN, Denmark — Europe’s pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by U.S. President Donald Trump fade.

The pharmaceutical industry has until now been exempt from trade levies, but Trump confirmed last week that he would soon impose tariffs on the sector.

Drugmakers are now lobbying the president for a phased approach to duties on imports to the U.S., Reuters reported Tuesday, citing four sources familiar with the discussions. The sources said the levies may not be announced Wednesday but were likely inevitable.

Gradual implementation of tariffs on the sector could reduce the immediate financial hit and allow companies time to relocate their manufacturing stateside. Nevertheless, some firms have warned that the lack of clarity is already having negative secondary effects.

“For us, what is more important is not only the impact of tariffs, it’s also the impact it makes on the market,” Ester Baiget, CEO of Danish biotech firm Novonesis, told CNBC Tuesday.

“When you bring tariffs, it drives uncertainty, and when you [are] uncertain, you pause, you pause innovation, you post launches, you pause investments,” said Baiget, whose firm derives around 30% of its sales from the U.S. but has also been boosting its manufacturing presence in the country.

Europe’s pharma industry braces for tariffs as carve-out hopes fade

Denmark is one of Europe’s largest pharma and biotech hubs, home to companies including Wegovy-maker Novo Nordisk and vaccine-producer Bavarian Nordic — both of which have high exposure to the U.S.

Novo Nordisk’s chairman told CNBC last week that the company was not speculating ahead of Trump’s tariff announcement and was instead focused on remaining flexible.

“It doesn’t make a lot of sense to speculate too much,” Chairman Helge Lund told CNBC on the sidelines of the Danish pharmaceutical giant’s Annual General Meeting. “We are laser-focused on what we can impact.”

Still, questions have been asked about how tariffs might impact U.S. sales of Novo’s hugely popular obesity and diabetes treatments — and the implications for U.S. rival and Zepbound-maker Eli Lilly. Lund would not be pressed on what share of its weight-loss drug sales derived from U.S. plants, instead pointing to the firm’s “very significant” manufacturing set-up in the U.S.

‘No. 1 question on investors’ minds’

The threat of tariffs has added to uncertainty within the investment landscape too. Speaking to CNBC Monday, Emily Field, head of European pharmaceuticals research at Barclays, cited tariffs as the “No. 1 question on investors’ minds.”

Pharma tariffs the 'number one question' on investors' minds, Barclays says

Morten Bødskov, Denmark’s minister for industry, business and financial affairs, told CNBC Tuesday that he was liaising with the country’s pharmaceutical industry and corporates more broadly about the potential impact of tariffs on the small, export-heavy economy.

“We are, of course, in close dialog with them,” Bødskov said. “It’s our job to bring them into discussions on the way the world is changing. Many of them are world-leading companies, so it’s our job to help them to see the perspectives of future markets,” he added.

However, he noted that it was unclear whether the Trump administration could be persuaded to roll back on its protectionist policies, or make allowances for certain sectors.

For companies like Novonesis, meanwhile, Baiget said it was a matter of watching events “very closely” — and readying for action if needed.

“There is a lot of volatility, and there is a lot of rapidly moving trends,” she said. “It’s important that we decouple, and we also learn how to maybe buffer some of them.”

Credit: Source link

ShareTweetSendSharePin
Previous Post

Braves’ Reynaldo López to undergo shoulder surgery

Next Post

Aliens, rovers and energy crystals: How Lego’s obsession with detail has kept fans hooked for 92 years and counting

Related Posts

Mohamed El-Erian says Trump tariffs risk US recession
News

Mohamed El-Erian says Trump tariffs risk US recession

April 4, 2025
China’s response to U.S. tariffs will likely focus on stimulus, trade
News

China’s response to U.S. tariffs will likely focus on stimulus, trade

April 4, 2025
How far is India from creating its own DeepSeek?
News

How far is India from creating its own DeepSeek?

April 4, 2025
Trump tariffs will impact Apple’s non-China supply chains
News

Trump tariffs will impact Apple’s non-China supply chains

April 4, 2025
Small-cap benchmark Russell 2000 becomes first major U.S. stock measure to enter bear market
News

Small-cap benchmark Russell 2000 becomes first major U.S. stock measure to enter bear market

April 3, 2025
Trump ‘liberation day’ tariffs: Biggest winners and losers
News

Trump ‘liberation day’ tariffs: Biggest winners and losers

April 3, 2025
Next Post
Aliens, rovers and energy crystals: How Lego’s obsession with detail has kept fans hooked for 92 years and counting

Aliens, rovers and energy crystals: How Lego’s obsession with detail has kept fans hooked for 92 years and counting

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

Elon Musk announces Neuralink’s first human implant of Blindsight coming this year

Elon Musk announces Neuralink’s first human implant of Blindsight coming this year

April 3, 2025
Treasury Secretary Bessent says the American dream is not about ‘access to cheap goods’

Treasury Secretary Bessent says the American dream is not about ‘access to cheap goods’

March 6, 2025
Education secretary says Columbia is on track to recover funding

Education secretary says Columbia is on track to recover funding

March 23, 2025
Amazon Spring Sale tech deals under : The best sales on our favorite budget gear

Amazon Spring Sale tech deals under $50: The best sales on our favorite budget gear

March 25, 2025
Europe’s pharma industry braces for tariffs as carve-out hopes fade

Europe’s pharma industry braces for tariffs as carve-out hopes fade

April 2, 2025
Austin Wells repays Yankees’ faith with historic Opening Day

Austin Wells repays Yankees’ faith with historic Opening Day

March 28, 2025
Alibaba 0 billion stock rally fueled by AI, Jack Ma return

Alibaba $100 billion stock rally fueled by AI, Jack Ma return

March 28, 2025

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • Foreign college students are now losing their visas and being ordered to leave over misdemeanor crimes or traffic infractions
  • Mohamed El-Erian says Trump tariffs risk US recession
  • Two allegedly brought guns into Australian Football League match
  • Europe has caught a workplace absenteeism bug costing it billions of euros

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In